Bioanalytical method development and validation of vildagliptin a novel dipeptidyl peptidase iv inhibitor by RP-HPLC method

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 119-123

  Pharne, A B ^b   Santhakumari, B ^a   Ghemud, A S ^c   Jain, H K ^b   Kulkarni, M J ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b Department of Pharmaceutical Chemistry   (India)

^c SINHGAD COLLEGE OF PHARMACY   (India)

Author keywords

HPLC; MS; Tolbutamide; Vildagliptin

Indexed keywords

TOLBUTAMIDE; VILDAGLIPTIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RETENTION; DRUG SELECTIVITY; DRUG STABILITY; HUMAN; LINEARITY; MEASUREMENT PRECISION; PHARMACOLOGICAL PARAMETERS; PLASMA; PRECIPITATION; PROCESS OPTIMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RUGGEDNESS; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 84866339782     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. U. S. Department of Health and Human Services Food and Drug administration Centre for Drug Evaluation and Research (CDER) Centre for Veterinary Medicine (CVM), Guidance for Industry Bioanalytical Method Validation, May 2001 BP.
2. McIntosh CH, Demuth HU, Pospisilik JA, Pederson R., Dipeptidyl peptidase IV inhibitors. How do they work as new antidiabetic agents? Regul Pept. 2005, 159-165.
3. Weber AE. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J Med Chem. 47, 2004, 4135-4141.
4. Lauster CD, McKaveney TP, Muench SV. Levalbuterol: A novel oral therapy for type 2 diabetes mellitus. Am J Health Syst Pharm. 64, 2007, 1265-1273.
5. 14C] Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans, Drug Metabolism and Disposition, 37, 2009, 536-544.
6. Roger L. Nation, Geoffrey W. Peng and Win L. Chiou. Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma. J Chrom B. 146, 1978, 121-131.
7. Cornelius Hess, Frank Musshoff, Burkhard Madea. Simultaneous identification and validated quantification of 11 oral hypoglycemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry, Analytical and bioanalytical chemistry. 400, 2011, 33-41.
8. Bijay Kumar Sahoo, Jayanti Mukherjee, Tapan Kumar Pal. Development and validation of a high performance liquid chromatographic method for Bioanalytical application with RanitidineHCL. Int J Pharm Pharm Sci, 3, 2011, 34-38.
9. S. V. S. G. B. Prasad, Savithiri Shivakumari, T. Sudhir, R. Mital, G. Devala Rao. LC/MS/MS method for the simultaneous estimation of Losartan potassium and Irbesartan in rat plasma, IJPPS, 1, 2009, 206-215.
10. G. Hendriks, Review Theoretical models in LC based bioanalytical method development, Journal of Pharmaceutical and Biomedical Analysis, 49, 2009, 1-10.
11. International Conference on Harmonization (ICH), Validation of analytical methods definitions and terminology, ICH Q2 A, 1994.
12. International Conference on Harmonization (ICH), Validation of analytical methods: methodology, ICH Q2 B, 1996.
13. Guidance for Industry, Bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration center for Drug Evaluation and Research Centre (CDER), Center for Veterinary Medicine (CVM) (2001)
14. http://www/fda. gov/cder/guidance/index. htm